Share
Latest episode
32. Stronger together: changing the future of muscle wasting condition
29:45||Ep. 32Listen to our Rare Disease Day Optimum Perspecitives podcast special featuring Tahira Mathur, Patient Advocate and Kate Adcock, Director of Research & Innovation at Optimum's chosen charity Muscular Dystrophy UK, alongside Jasper Morrow, consultant neurologist at University College London Hospital. This emotional yet hopeful episode highlights the importance of raising awareness of rare conditions, while discussing patient care, diagnosis, and genetic testing for Muscular Dystrophy. If you would like to contribute to the life changing work of Muscular Dystrophy UK, or find out more about Tahira's story living with GNE myopathy, visit her page here: Tahira's Team - JustGiving
More episodes
View all episodes
31. How bioengineered spider silk-based proteins are changing the world
12:14||Ep. 31Want to know how bioengineered spider silk protein fibres can be applied within the textile, biomedical and automobile industries? In the latest episode of Optimum Perspectives, hear from Benoit Cugnet, Head of Fiber Business Unit at AMSilk, on how this German biotech is changing the face of advanced materials.30. How to have a perfect IPO on NASDAQ
23:53||Ep. 30Want to know how to prepare yourself for the perfect IPO on NASDAQ? Hear from Lynn Lewis, CEO of Gilmartin Group, Optimum’s US partner, on the considerations and milestones to reach before listing.29. Ariceum Therapeutics: Pioneering research into next-generation radiopharmaceutical therapy targeting hard-to-treat cancers
09:58||Ep. 29The latest epiosde of Optimum Perspectives Podcast features Germo Gericke, CMO of Ariceum Therapeutics. Listen as he discusses how the company aims to improve outcomes for patients with lung cancer with radioligand therapy this Lung Cancer Awareness Month.28. Kling Biotherapeutics: Using B cell tech to discover new targets and antibodies in cancer
09:17||Ep. 28Great new insights in the Optimum Perspectives' latest podcast edition featuring Stefano Gullà, Chief Scientific Officer at Kling Biotherapeutics, about the growing role of B cell technology in cancer therapy.27. DISCO Pharmaceuticals looks to unlock new drugs with “surfaceome” technology
15:51||Ep. 27In this podcast to mark Lung Cancer Awareness Month, Optimum’s Richard Staines speaks to Roman Thomas, CEO and founder of Disco Pharmaceuticals, on breakthroughs that have improved patient outcomes, and the company’s efforts to help develop new therapies with its “surfaceome” technology.26. SpliceBio: Celebrating progress in ophthalmology research on World Sight Day
11:42||Ep. 26Optimum’s Richard Staines talks to Feride Sahin, Senior Director of Clinical Development at Splice Bio about the importance of World Sight Day, which takes place this week.